For more details on each type of training, please see below. ...
Please refer to the “Corporate Governance Report” below for details on ou...
We set targets for sustainability, including environmental and occupation...
We are aware of our responsibility as a pharmaceutical company involved i...
Contributing to sustainable social development through business activitie...
We are implementing work style reform to contribute to employing and reta...
We conduct a variety of social contribution activities to contribute to t...
Handling of the active pharmaceutical ingredient (API) and environmental ...
External evaluation of environmental, societal and corporate governance e...
Materiality: Our most important issues In FY2021, based on the ne...
We have been producing a radio program called "The Moment of Change" sinc...
Creating a road map for reduction of GHG emissionsActions against TCFD ri...
Sustainability Report 2023 Sustainability Report 2023 Susta...
Basic Approach Information assets are very important management resour...
The Compliance Management Department and the Sales and Marketing Departme...
We organized a resource recycling sub-committee consisting of waste manag...
Contribution by ONO to the SDGs We contribute to Goal 3, Goal ...
We implement all the principles of the Corporate Governance Code stipulat...
Our website refers to the Global Reporting Initiative (GRI) Standards.The...
The Board of Directors supervises materiality (important issues) in susta...
As for the results of progress against the greenhouse gas emission redu...
The total volume of our industrial waste in FY2022 increased by 13.1 tons...
